Synchronous Fluorescence Determination of Ciprofloxacin in the Pharmaceutical Formulation and Human Serum Based on the Perturbed Luminescence of Rare-Earth Ions

Changlun Tong,Xiajun Zhuo,Yun Guo,Yueheng Fang
DOI: https://doi.org/10.1016/j.jlumin.2010.05.034
IF: 3.6
2010-01-01
Journal of Luminescence
Abstract:A simple, rapid and sensitive synchronous fluorescence method was developed for the determination of ciprofloxacin (CPFX) in the pharmaceutical formulation and human serum. The results show that when Y3+ is added into the CPFX solution, the characteristic fluorescence of Y3+ is not emitted whereas the fluorescence intensity of CPFX is significantly enhanced. The synchronous fluorescence technology is employed in this method to directly determine trace amount of CPFX in human serum. A linear relationship between the fluorescence intensity and the CPFX concentration is obtained in the range of 1.0×10−9 ∼5.0×10−6molL−1. The limit of detection (LOD) of this method attains as low as 2.0×10−10molL−1 (S/N=3). The selectivity of this method is also very good. Common metal ions, rare-earth ions and some pharmaceuticals, which are usually used together with CPFX in the clinic, do not interfere with the determination of CPFX under general conditions.
What problem does this paper attempt to address?